Clinical Trial Update: Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed whether rosuvastatin could prevent progression of atherosclerosis in HIV-positive patients; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• HIV Infection

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: University of British Columbia | Conditions: Atherosclerosis, HIV Infections | Phase 4 | Status: TERMINATED